Satvat Ali J. 4
4 · BridgeBio Pharma, Inc. · Filed Jun 22, 2021
Insider Transaction Report
Form 4
Satvat Ali J.
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-17+38,895→ 38,895 totalExercise: $62.63Exp: 2031-06-16→ Common Stock (38,895 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.